A Single-Dose, Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Five-Period Crossover, Dose-Ranging Efficacy and Safety Comparison of Albuterol Spiromax and ProAir HFA in Pediatric Patients With Persistent Asthma
Latest Information Update: 07 Nov 2021
Price :
$35 *
At a glance
- Drugs Salbutamol (Primary) ; Salbutamol sulfate (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Sponsors Teva Branded Pharmaceutical Products R&D; Teva Pharmaceutical Industries
- 18 May 2016 Results presented at the 112th International Conference of the American Thoracic Society
- 07 Mar 2016 Primary endpoint has been met. (Baseline-Adjusted Area-Under-The-Percent-Predicted Forced Expiratory Volume In 1 Second (FEV1) Versus Time Curve Over 6 Hours Post-Dose), according to results presented at the 2016 Annual Meeting of the American Academy of Allergy, Asthma and Immunology.
- 07 Mar 2016 Results presented at the 2016 Annual Meeting of the American Academy of Allergy, Asthma and Immunology